Dr Yehuda Handelsman on How Insulin Therapy Advances Can Boost Patients' Quality of Life

With new technologies that allow insulin to be delivered much more easily and at a targeted speed, diabetes treatment is less likely to interfere with patients’ lives, explained Yehuda Handelsman, MD, FACP, FACE, FNLA, medical director and principal investigator at the Metabolic Institute of America.

Related Videos

Related Content

Advertisement

June 13th 2025

Fatty Liver Found in Half of Patients With Type 2 Diabetes, Study Finds

Pearl Steinzor

Nonalcoholic fatty liver disease (NAFLD) was linked to elevated liver enzymes in type 2 diabetes mellitus (T2DM) in a recent study, urging early detection and comprehensive care.

June 10th 2025

Blister Packs May Help Solve Medication Adherence Challenges and Lower Health Care Costs

Brooke McCormick Julia D. Lucaci, PharmD, MS

Julia Lucaci, PharmD, MS, of Becton, Dickinson and Company, discusses the benefits of blister packaging for chronic medications, advocating for payer incentives to boost medication adherence and improve health outcomes.

June 10th 2025

DASH-Style Diet Lowers Blood Pressure in Type 2 Diabetes

Pearl Steinzor

Sodium reduction is key to lowering blood pressure in adults with type 2 diabetes, a study finds.

May 29th 2025

Laundromats as a New Frontier in Community Health, Medicaid Outreach

Brooke McCormick Lindsey Jeanne Leininger, PhD Allister Chang, MPA

Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.

June 4th 2025

Proactively Protecting Mental and Physical Health During Peak Allergy Season With Gary Falcetano, PA-C, AE-C

Cameron Santoro Gary Falcetano, PA-C, AE-C

Gary Falcetano, PA-C, AE-C, explains that proactively managing seasonal allergies can significantly decrease the overall inflammatory burden, thereby improving both physical symptoms and potentially mitigating neuroinflammation's impact on mental well-being.

June 3rd 2025

Understanding the Mental Health Burden of Chronic Allergies and Early Diagnosis: Insights From Thermo Fisher's Gary Falcetano

Cameron Santoro Gary Falcetano, PA-C, AE-C

Gary Falcetano, PA-C, AE-C, features insights on how unaddressed chronic allergy symptoms contribute to mental health burdens and the critical role of early immunoglobulin E trigger identification in managing both physical and psychological wellbeing.

Related Content

Advertisement

June 13th 2025

Fatty Liver Found in Half of Patients With Type 2 Diabetes, Study Finds

Pearl Steinzor

Nonalcoholic fatty liver disease (NAFLD) was linked to elevated liver enzymes in type 2 diabetes mellitus (T2DM) in a recent study, urging early detection and comprehensive care.

June 10th 2025

Blister Packs May Help Solve Medication Adherence Challenges and Lower Health Care Costs

Brooke McCormick Julia D. Lucaci, PharmD, MS

Julia Lucaci, PharmD, MS, of Becton, Dickinson and Company, discusses the benefits of blister packaging for chronic medications, advocating for payer incentives to boost medication adherence and improve health outcomes.

June 10th 2025

DASH-Style Diet Lowers Blood Pressure in Type 2 Diabetes

Pearl Steinzor

Sodium reduction is key to lowering blood pressure in adults with type 2 diabetes, a study finds.

May 29th 2025

Laundromats as a New Frontier in Community Health, Medicaid Outreach

Brooke McCormick Lindsey Jeanne Leininger, PhD Allister Chang, MPA

Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.

June 4th 2025

Proactively Protecting Mental and Physical Health During Peak Allergy Season With Gary Falcetano, PA-C, AE-C

Cameron Santoro Gary Falcetano, PA-C, AE-C

Gary Falcetano, PA-C, AE-C, explains that proactively managing seasonal allergies can significantly decrease the overall inflammatory burden, thereby improving both physical symptoms and potentially mitigating neuroinflammation's impact on mental well-being.

June 3rd 2025

Understanding the Mental Health Burden of Chronic Allergies and Early Diagnosis: Insights From Thermo Fisher's Gary Falcetano

Cameron Santoro Gary Falcetano, PA-C, AE-C

Gary Falcetano, PA-C, AE-C, features insights on how unaddressed chronic allergy symptoms contribute to mental health burdens and the critical role of early immunoglobulin E trigger identification in managing both physical and psychological wellbeing.